🌟 Exciting Opportunity for Innovators! Are you navigating the evolving landscape of patent law? The 2023 Supreme Court ruling on enablement has reshaped how inventors and patent holders approach their claims. Understanding this change is critical to ensuring your patent applications meet the new requirements. Join us for "Lab to Impact: IP Module on Practical Insights into Enablement" to gain valuable insights into this game-changing development: 📅 Thursday, January 23 ⏰ 12 – 1 p.m. ET 💻 RSVP for this Virtual Webinar: https://bit.ly/3OViVLl 🎙️ Featured Speaker: Yvonne Shyntum, Partner at Pabst Patent Group, will delve into the Court's interpretation of enablement and provide actionable strategies to ensure compliance. With expertise in biotechnology and pharmaceuticals, Dr. Shyntum will share practical advice for innovators and practitioners alike. Don't miss this opportunity to stay ahead in the world of innovation and patents! #IntellectualProperty #Innovation #Patents #Biotech #TechTransfer
Center for Technology Licensing at Cornell University (CTL)
Research Services
Ithaca, New York 1,429 followers
The Center for Technology Licensing (CTL) is Cornell University's technology transfer office.
About us
The Center for Technology Licensing (CTL) is Cornell University’s technology transfer office. We manage technology for Cornell’s Ithaca campus, Weill Cornell Medicine (WCM), Cornell Tech, and Cornell AgriTech in Geneva. CTL’s mission is to bring the University’s scientific discoveries, technological innovations, and medical advances to the marketplace for societal benefit and to foster economic development within New York State and across the nation. Reflective of Cornell’s broad research endeavors, CTL manages inventions from disciplines including, but not limited to, chemistry, engineering, information technologies, materials science, medicine, plant science, and veterinary medicine. CTL licenses Cornell technologies to industry partners from all 50 states and in Europe, Asia-Pacific, the Middle East, and Central and South America. Cornell inventions are patented in over 40 countries.
- Website
-
http://ctl.cornell.edu
External link for Center for Technology Licensing at Cornell University (CTL)
- Industry
- Research Services
- Company size
- 11-50 employees
- Headquarters
- Ithaca, New York
- Type
- Privately Held
- Specialties
- Commercialization, Technology Venture, Technology Startups, and Technology Transfer
Locations
-
Primary
395 Pine Tree Rd
Suite 310
Ithaca, New York 14850, US
-
1155 York Avenue
New York, New York 10065, US
Employees at Center for Technology Licensing at Cornell University (CTL)
-
Sean X. Hu
CEO of Rapafusyn Pharmaceuticals, where we break the pharma industry's drug-discovery-bottleneck using our macrocyclic "molecular glue" platform
-
Nyron Khan
Proven biotech executive with deep enterprise experience
-
Alan Belicha, PhD
Life sciences business development and licensing leader with over $1.3B in transactions
-
Marie K. Donnelly Ph.D, CLP
Business Development and Licensing Associate
Updates
-
Center for Technology Licensing at Cornell University (CTL) reposted this
Several recurring themes were touched upon by speakers and panelists at the Dean’s Symposium on Innovation and Entrepreneurship on Dec 18. As Dr. Krystyn J. Van Vliet, Vice President for Research and Innovation at Cornell University, pointed out, Weill Cornell Medicine innovators are highly motivated by their patients to improve how things are done. Innovators may have different paths to commercialization or entrepreneurship, but innovation requires a lot of conversation and collaboration among them across Cornell University. A lot still needs to be innovated for women’s health. Tamatha Fenster MD, MS., Bobak Mosadegh Ph.D. and Rache Simmons MD MS MBA, all agreed that patients are the most important stakeholders when deciding what to pursue as invention/innovation. Each panelist introduced their women’s health innovation and shared their experience in the process. The panel believed physicians should be brave enough to move away from standard procedures as well as network with experts in engineering and business. The people connection is what transforms an innovative idea from conversation to prototype and ultimately, a product in the market that serves the patients’ needs. Clinicians possess the unique advantage of knowing health care pain points and seeing first-hand the problems patients and nurses have. However, they also face the unique challenge of lacking dedicated time to develop solutions and marketing and administrative supports along the way. All panelists of the “Beyond Therapeutics” innovation discussion, Drs. Keith Hentel, Denise Howard, Conor Liston and Rahul Sharma, MD, MBA, FACEP, discovered a clinical pain point in their field. They resolved that with innovation in the form of appropriate use criteria in imaging, a pre-op patient education and counseling app, psychological evaluation and telemedicine tools. For them, being a clinician-innovator means thinking out of the box, persistence, team work among colleagues and using available Cornell assets to pressure test innovation.
-
Two Cornell University professors have been elected to the National Academy of Inventors' 2024 class for innovations they've developed through their research 🙌 🍎 Herb Aldwinckle, a professor emeritus of plant pathology and plant-microbe biology in the Cornell University College of Agriculture and Life Sciences, researches disease management in plants and strengthening plant varieties through hybridization. 🥼 Ulrich Wiesner, the Cornell Engineering Spencer T. Olin Professor, creates multifunctional nanomaterials with applications in cancer therapeutics, virus filtration, and more. Learn more about the impact these two inventors have made: https://bit.ly/3VG5i6n
-
🔍 Curious about Intellectual Property or Tech Transfer? Join our CTL Business Development and Licensing team members for December office hours – have your questions about intellectual property answered and gain more information about the advancement of IP filings and venture creation. 📅 Office Hours: 🔬 Life Sciences Marie Donnelly on Tuesday, December 17th 2-4 PM ET🖇️ https://bit.ly/40vnkf3 Sarah Ward on Wednesday, December 18th 1-3 PM ET 🖇️ https://bit.ly/40vnkf3 ⚙️ Physical Science Maxim Shabrov on Tuesday, December 17th 12-2 PM ET 🖇️ https://bit.ly/4ftcLhj Ryan Luebke virtually on Tuesdays, Wednesdays, and Thursdays from 2-4 PM ET 🖇️ https://bit.ly/4hA0eKc Whether you're navigating your first IP filing or looking to bring a new technology to market, these sessions are a valuable resource for taking the next step. #IntellectualProperty #Innovation #TechTransfer #IPFilings #StartupSupport
-
Licensing and IP professionals do vital behind-the-scenes work to help inventors make a real-world impact with their research. We're honoring them today for #TechTransferProfessionalsDay! 💡 Thank you to our dedicated team of tech transfer professionals at Cornell University for helping to bring life-changing innovations out of the lab and into the market 👏
-
📢 Got questions about intellectual property, licensing, or venture creation? Check out the December Office Hours at CTL! These one-on-one sessions allow you to discuss your ideas with industry experts and get tailored guidance. 📅 Office Hours: 🔬 Life Sciences Stephen Nowak on Thursday, December 12th 1-3 PM ET 🖇️ https://bit.ly/40vnkf3 Marie Donnelly on Tuesday, December 17th 2-4 PM ET🖇️ https://bit.ly/40vnkf3 Sarah Ward on Wednesday, December 18th 1-3 PM ET 🖇️ https://bit.ly/40vnkf3 ⚙️ Physical Science Maxim Shabrov on Tuesday, December 17th 12-2 PM ET 🖇️ https://bit.ly/4ftcLhj Ryan Luebke virtually on Tuesdays, Wednesdays, and Thursdays from 2-4 PM ET 🖇️ https://bit.ly/4hA0eKc Whether you're navigating your first IP filing or looking to bring a new technology to market, these sessions are a valuable resource for taking the next step. #IntellectualProperty #Innovation #TechTransfer #IPFilings #StartupSupport
-
🗓️ Calling Cornell’s life sciences community! Join Weill Cornell Medicine on Wednesday, December 18, for an inspiring symposium celebrating the transformative power of innovation in medicine and biotechnology. Highlights include: 🌟 Faculty panels showcasing groundbreaking research and innovation 🌟 Remarks from Dr. Krystyn J. Van Vliet, Cornell’s Vice President for Research and Innovation 🌟 A fireside chat with Dr. Rachel Haurwitz, President & CEO of Caribou Biosciences, hosted by Dr. Robert A. Harrington, Dean of Weill Cornell Medicine 📍 Location: Griffis Faculty Club, NYC, or attend virtually via Zoom ✨ Don’t miss this opportunity to connect with thought leaders and innovators shaping the future of medicine and biotechnology. 📅 Register now: https://lnkd.in/gqcyF5VC #LifeSciences #Biotechnology #Innovation #Entrepreneurship #CornellUniversity
Eighth Annual Dean's Symposium on Innovation and Entrepreneurship
eventbrite.com
-
⭐️ #ICYMI: The latest workshop in our Lab to Impact Series, covering Founder's Equity, is now available on our Youtube channel! Thank you to Nabil Ullah, Senior Investment Analyst at Osage University Partners (OUP), for leading this session on navigating equity splits among startup co-founders, early employees, and advisors. 🔗 Watch: https://lnkd.in/gtvsPr2Z
-
📣 New opportunity for #batterytech and #energystorage startups! New Energy New York's ChargeUp Accelerator provides innovators and entrepreneurs with a $25,000 participation stipend, connections to investors, and follow-on funding opportunities, including up to $100,000 for technical development 🔋 Learn more & apply by January 15, 2025: https://lnkd.in/gtX6j3y6
-
Center for Technology Licensing at Cornell University (CTL) reposted this
The Accelerating BioVenture Innovation (ABI) Final Pitch Event is only two days away! Join us this Thursday, December 5, for a night of presentations and network with investors, ecosystem collaborators and industry representatives who served as mentors and lecturers throughout the program. Come cheer for the five finalist teams. These are the innovations they are presenting: • MindSure - Non-invasive device for determining subtypes of Major Depressive Disorder • Pulmargeutics - Small molecule targeting EMP-2 to treat COPD • Senecta Therapeutics - Fucoidan nanoparticles combined with drug payloads that target fibrotic tissue • Tornado Therapeutics - Platform to generate mRNA virus-like particles (VLPs) used initially to develop a norovirus vaccine • VisionPro - Non-invasive, high-frequency ultrasound device for early and quantitative detection of myopia https://lnkd.in/emdQMN6F Weill Cornell Medicine Center for Technology Licensing at Cornell University (CTL)
Accelerating BioVenture Innovation Final Pitch Event
eventbrite.com